Market revenue in 2024 | USD 18.3 million |
Market revenue in 2030 | USD 33.7 million |
Growth rate | 10.8% (CAGR from 2025 to 2030) |
Largest segment | Dystonia |
Fastest growing segment | Obsessive Compulsive Disorder (OCD) |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pain Management, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinsons Disease, Depression, Dystonia |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dystonia was the largest segment with a revenue share of 71.58% in 2024. Horizon Databook has segmented the Switzerland deep brain stimulation devices market based on pain management, essential tremor, obsessive compulsive disorder (ocd), parkinsons disease, depression, dystonia covering the revenue growth of each sub-segment from 2018 to 2030.
The deep brain stimulation devices market in Switzerland is estimated to exhibit constant growth rate over the forecast period. This can be attributed to increasing geriatric population and growing prevalence of neurological diseases.
Companies are continuously trying to develop new devices and focusing on research activities. Moreover, favorable insurance policies contribute to the market growth.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account